Form 8-K - Current report:
SEC Accession No. 0001683168-25-001236
Filing Date
2025-02-26
Accepted
2025-02-26 13:57:29
Documents
14
Period of Report
2025-02-21
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm   iXBRL 8-K 29408
2 LETTER FROM MARCUM LLP pharmacyte_ex1601.htm EX-16.1 2782
  Complete submission text file 0001683168-25-001236.txt   207048

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pmcb-20250221.xsd EX-101.SCH 3021
4 XBRL LABEL FILE pmcb-20250221_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pmcb-20250221_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_8k_htm.xml XML 3679
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 25668896
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)